Litcius/Paper detail

Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial

Qing-Bin Zeng, D. Zou, Xingbing Huang, Dewei Shang, Xiong Huang, Xin-Hu Yang, Yu-Ping Ning, Lloyd Balbuena, Yu‐Tao Xiang, Wei Zheng

2024Journal of Affective Disorders12 citationsDOI

Topics & Concepts

Electroconvulsive therapyTreatment-resistant depressionPropofolAntidepressantAnestheticDepression (economics)KetamineRandomized controlled trialAnesthesiaMedicinePsychologyMajor depressive disorderPsychiatryInternal medicineAnxietyCognitionEconomicsMacroeconomicsElectroconvulsive ShockElectroconvulsive Therapy StudiesTreatment of Major DepressionAnesthesia and Sedative Agents
Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial | Litcius